Operating
Operating lease right-of-use asset amortization
Edwards Lifesciences Operating lease right-of-use asset amortization decreased by 1.5% to $6.5M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.6%, from $6.1M to $6.5M. Over 4 years (FY 2021 to FY 2025), Operating lease right-of-use asset amortization shows relatively stable performance with a -2.4% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2020
Last reportedQ1 2026May 6, 2026
How to read this metric
An increase suggests a larger footprint of leased assets, while a decrease suggests a reduction in lease obligations.
Detailed definition
This reflects the non-cash amortization of the right-of-use asset created under lease accounting standards. It represent...
Peer comparison
Standard for companies with significant real estate or equipment lease portfolios.
Metric ID:
operating_operating_lease_right_of_use_asset_amortizatio_94fda1Historical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7M | $7.1M | $7.1M | $7.1M | $6.8M | $6.7M | $6.6M | $6.8M | $6.9M | $7M | $7.5M | $7.7M | $7.4M | $6.5M | $6.2M | $6.1M | $6.4M | $6.8M | $6.6M | $6.5M |
| QoQ Change | — | +1.4% | +0.0% | +0.0% | -4.2% | -1.5% | -1.5% | +3.0% | +1.5% | +1.4% | +7.1% | +2.7% | -3.9% | -12.2% | -4.6% | -1.6% | +4.9% | +6.3% | -2.9% | -1.5% |
| YoY Change | — | — | — | — | -2.9% | -5.6% | -7.0% | -4.2% | +1.5% | +4.5% | +13.6% | +13.2% | +7.2% | -7.1% | -17.3% | -20.8% | -13.5% | +4.6% | +6.5% | +6.6% |
Range$6.1M – $7.7M
CAGR-1.5%
Avg YoY Growth-1.3%
Median YoY Growth-0.7%
Current Streak2 quarters decline
Operating lease right-of-use asset amortization at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's operating lease right-of-use asset amortization?
- Edwards Lifesciences (EW) reported operating lease right-of-use asset amortization of $6.5M in Q1 2026.
- How has Edwards Lifesciences's operating lease right-of-use asset amortization changed year-over-year?
- Edwards Lifesciences's operating lease right-of-use asset amortization increased by 6.6% year-over-year, from $6.1M to $6.5M.
- What is the long-term trend for Edwards Lifesciences's operating lease right-of-use asset amortization?
- Over 4 years (2021 to 2025), Edwards Lifesciences's operating lease right-of-use asset amortization has grown at a -2.4% compound annual growth rate (CAGR), from $28.5M to $25.9M.
- What does operating lease right-of-use asset amortization mean?
- The non-cash expense for the usage of leased assets.